… intracellular accumulation of gadolinium-DTPA, but is unlikely. Further study will be required
to determine the clinical correlates of myocardial enhancement in Anderson-Fabry disease. …

… late gadolinium enhancement (LGE) areas. Error bar = 1 SD. (B) Corresponding LGE, T1,
and T2 maps in Fabry disease (… with the area of late gadolinium enhancement. cMI = chronic …

… MRI findings in patients with confirmed Fabry disease to date. In this study, left ventricular
hypertrophy (LVH) and late gadolinium enhancement (LGE) were independent predictors of …

… Cardiac involvement is the leading cause of mortality in Fabry disease (FD). Late gadolinium
enhancement (LGE) on cardiac magnetic resonance imaging predicts adverse cardiac …

… tures of the disease and key pathophysiologic components driving the natural history of Fabry
… Late gadolinium enhancement (LGE) imaging is an established and highly reproducible …

… Fabry Disease (AFD) is a storage disease that mimics hypertrophic cardiomyopathy. Late
gadolinium enhancement … wall, but how an intracellular storage disease causes focal LGE is …

… evaluated the characteristics of LGE in our population of Fabry disease. … Fabry disease
who were followed at Jikei University Hospital and successfully underwent gadolinium-enhanced …

… intracellular accumulation of gadolinium-DTPA, but is unlikely. Further study will be required
to determine the clinical correlates of myocardial enhancement in Anderson-Fabry disease. …

… late gadolinium enhancement (LGE) [11], [12], [13]. Fabry disease (FD) is a lysosomal storage
disease … Finally, we evaluated 3D LGE in patients with Fabry disease and HCM but not for …

… Fabry disease is a rare X-linked genetic disorder in which cardiac manifestations include …
) as late gadolinium enhancement (LGE) of the myocardium. Fabry's disease is an important …